-
Columbus Public Health announced Monday they are offering COVID-19 Pfizer booster shots for those eligible.
-
Pfizer and BioNTech say that early trial results show their vaccine established a strong antibody response against the coronavirus. FDA review is still needed.
-
Pfizer says it will submit the clinical trial results "as soon as possible" to the U.S. Food and Drug Administration, and is hoping to start vaccinating children before the next school year.
-
Pfizer and Moderna each agreed to supply 100 million doses of COVID-19 vaccine to the U.S. by the end of March. With just under three weeks left, both companies have their work cut out for them.
-
As the new Johnson & Johnson COVID-19 vaccine rolls out, the health care community is trying to ward off misconceptions about it. The vaccine's one-shot feature may be what wins many over.
-
"We've now purchased enough vaccine supplies to vaccinate all Americans," Biden said on Thursday. "Now we're working to get those vaccines into the arms of millions of people."
-
Ohio’s effort to vaccinate citizens against COVID-19 have been hampered by a lack of supply. Gov. Mike DeWine said there is hope the state will begin…
-
Gov. Mike DeWine and his wife, first lady Fran DeWine, received the Pfizer coronavirus vaccine Tuesday at the Kettering Health Network Rural Health...
-
The Biden administration says it plans to buy an additional 100 million doses from both Moderna and Pfizer and pledges greater transparency with state and local leaders about supply expectations.
-
The two companies making COVID-19 vaccines each promised to deliver 100 million doses to the federal government by the end of March. So far, they appear to be running behind.